|4Jul 5, 1:20 PM ET

Nexvet Biopharma plc 4

4 · Nexvet Biopharma plc · Filed Jul 5, 2017

Insider Transaction Report

Form 4
Period: 2017-07-01
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2017-07-013,6000 total
    Exercise: $0.13From: 2017-07-01Exp: 2021-07-01Ordinary Shares (3,600 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2017-07-01$0.13/sh+3,600$4507,200 total
Holdings
  • Ordinary Shares

    (indirect: Elsing Pty Ltd.)
    8,800
Footnotes (1)
  • [F1]The reporting person has sole voting and dispositive power with respect to the reported securities.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT